Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

Ajinomoto Bio-Pharma Services and Revance Therapeutics have announced a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.